BioCryst Pharmaceuticals Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for BCRX, updated each market day.
BCRX AI Sentiment
AI sees no strong directional signal for BioCryst Pharmaceuticals Inc stock over the next 10 market days.
Prediction date: Oct. 9, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Sector
Exchange
Market Cap
$2,118,386,020
Cap Tier
Employees
435
Headquarters
DURHAM, NC
Listed Since
March 3, 1994
Website
BCRX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BCRX Volatility
BioCryst Pharmaceuticals Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
